Curileum

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.

BIOKURIS

The company develops biopolymer-based medical nutrition products for business-to-business customers to manage chronic gastrointestinal conditions such as irritable bowel syndrome.

cAMPfield

The company develops oral biopharmaceutical medicines for patients with immune-mediated inflammatory diseases, specifically focusing on treatments for inflammatory bowel disease.

Curzion Pharmaceuticals

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare fibrotic conditions like diffuse cutaneous systemic sclerosis.

Curegenix

This company develops small-molecule chemical drugs for the treatment of tumours and organ fibrosis for patients with stem cell related diseases.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

First Wave

The company develops oral and topical therapies targeting disease-causing immune cells to treat patients suffering from gastrointestinal and chronic inflammatory diseases.

Curve Therapeutics

This biotechnology company develops small molecule and cyclic peptide drugs for pharmaceutical partners and patients to treat cancer, immunology and inflammatory diseases.